Q32 Bio (QTTB) Receivables (2018 - 2021)

Q32 Bio (QTTB) posted quarterly Receivables of $100000.0 for Q3 2021, down 75.0% year-over-year from $400000.0 in Q3 2020, and down 50.0% quarter-over-quarter from $200000.0 in Q2 2021.

Q32 Bio (QTTB) Receivables (2018 - 2021) Analysis & Trends

Q32 Bio's Receivables history runs 4 years deep, the most recent figure standing at $100000.0 for Q3 2021.

  • In Q3 2021, Receivables fell 75.0% year-over-year to $100000.0; the TTM figure through Sep 2021 stood at $100000.0 (down 75.0% YoY), while the FY2020 annual figure was $400000.0, changed 0.0% from the prior year.
  • Receivables for Q3 2021 stood at $100000.0, down from $200000.0 in the prior quarter.
  • The five-year high for Receivables was $800000.0 in Q4 2018, with the low at $100000.0 in Q3 2021.
  • The 4-year median for Receivables is $350000.0 (2019), against an average of $350000.0.
  • The sharpest annual moves came in 2020 and 2021: Receivables jumped 100.0% in 2020, then plunged 75.0% in 2021.
  • Q32 Bio's Receivables stood at $800000.0 in 2018, then slumped by 50.0% to $400000.0 in 2019, then changed by 0.0% to $400000.0 in 2020, then slumped by 75.0% to $100000.0 in 2021.
  • Business Quant data shows QTTB's Receivables at $100000.0 in Q3 2021, $200000.0 in Q2 2021, and $300000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.93 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.06 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 1.84 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 912.74 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 215.33 Mn
10 Q32 Bio 359.61 Mn 253.31 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 100,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 300,000.00
Dec 31, 2020 400,000.00
Sep 30, 2020 400,000.00
Jun 30, 2020 400,000.00
Mar 31, 2020 400,000.00
Dec 31, 2019 400,000.00
Sep 30, 2019 300,000.00
Jun 30, 2019 300,000.00
Mar 31, 2019 200,000.00
Dec 31, 2018 800,000.00